hematopoietic system
• reduced hematocrit despite normal erythrocyte counts
|
microcytosis
(
J:105124
)
• 40% decrease in nonheme iron content in the spleen
• however, no differences are seen in iron levels in the brain and mice do not display splenomegaly or erythroid hyperplasia
|
homeostasis/metabolism
• increase in ferritin H- and L-chain levels in the duodenum and liver and a decrease in ferritin and ferroportin protein expression, but not mRNA levels, in the spleen
|
• 80% increase in non-heme iron content in the duodenum, with iron deposits in the duodenal villi but not the crypts
• however no differences in serum iron levels, total iron binding capacity, serum transferring saturation, or rate of iron transport across the duodenal mucosa
|
• 40% decrease in nonheme iron content in the spleen
• however, no differences are seen in iron levels in the brain and mice do not display splenomegaly or erythroid hyperplasia
|
• 50% increase in non-heme iron content in the liver
|
immune system
• 40% decrease in nonheme iron content in the spleen
• however, no differences are seen in iron levels in the brain and mice do not display splenomegaly or erythroid hyperplasia
|
behavior/neurological
N |
• do not observe any overt signs of neuropathology such as tremor or posture abnormalities
|
• locomotion is mildly affected, however do not display the neurodegenerative phenotype seen in homozygous Ireb2tm1Roua mice
|
digestive/alimentary system
• 80% increase in non-heme iron content in the duodenum, with iron deposits in the duodenal villi but not the crypts
• however no differences in serum iron levels, total iron binding capacity, serum transferring saturation, or rate of iron transport across the duodenal mucosa
|
liver/biliary system
• 50% increase in non-heme iron content in the liver
|